Technology Assessment
Biologics include a wide range of medicinal products such as vaccines, blood and blood components, allergenic, somatic cells, gene therapy, tissues, and recombinant therapeutic proteins. Gene-based and cellular biologics are at the forefront of biomedical research, and may be used to treat a variety of genetic and rare conditions for which no treatment is available.
BBCR experts are available to confidentially assess technologies for clients considering in-licensing or acquisition opportunities.